Polyphenol-Mediated Modulation of Oxidative Stress Pathways in Type 1 Diabetes: A Systematic Review

Alan Ho1, Harini Adivikolanu1, Dilan Patel1

  • 1Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

Insights

Dietary polyphenols can reduce oxidative stress in type 1 diabetes (T1D) preclinical models by boosting antioxidant defenses. While effects on blood sugar were mixed, polyphenols show promise for targeting redox imbalance in T1D.

Area of Science:

  • Biochemistry
  • Endocrinology
  • Nutritional Science

Background:

  • Oxidative stress is integral to type 1 diabetes (T1D) pathophysiology, impacting pancreatic beta-cell function and leading to complications.
  • Current T1D treatments focus on glycemic control, neglecting the critical role of redox imbalance.
  • Dietary polyphenols possess antioxidant and cytoprotective qualities, but their specific impact on T1D requires systematic evaluation.

Purpose of the Study:

  • To systematically review the effects of dietary polyphenols on oxidative stress and glycemic parameters in preclinical models of T1D.
  • To explore the mechanisms by which polyphenols may influence T1D pathogenesis, focusing on redox balance.
  • To assess the potential of polyphenols as adjunctive therapies for T1D.

Main Methods:

  • Systematic literature review of preclinical studies investigating polyphenol interventions in T1D models.
  • Analysis of data on oxidative stress markers (lipid peroxidation, reactive oxygen/nitrogen species, antioxidant enzymes) and glycemic parameters.
  • Evaluation of polyphenol effects on redox-sensitive signaling pathways, including Nrf2.

Main Results:

  • Polyphenols consistently attenuated oxidative stress markers, reducing lipid peroxidation and reactive species while enhancing endogenous antioxidants (SOD, catalase, glutathione).
  • These antioxidant effects were frequently associated with the modulation of redox-sensitive pathways, particularly Nrf2-dependent mechanisms.
  • Glycemic outcomes were variable, influenced by specific compounds and experimental designs, with oxidative stress modulation often occurring independently of glycemic changes.

Conclusions:

  • Dietary polyphenols demonstrate significant potential in mitigating oxidative stress in preclinical T1D models through redox balance modulation.
  • The observed effects on oxidative stress suggest a primary redox-mediated mechanism of action for polyphenols in T1D.
  • Future translational research should prioritize oxidative-stress-focused endpoints and evaluate polyphenols as complementary strategies for managing T1D-associated redox imbalance.

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...